• Dangerous games

    Employers' body Neasa is playing a potentially dangerous game, says Terry Bell.

  • Rational thinking

    All players should first consider the net result of their actions, says Leopold Scholtz.

  • Telkom's property poser

    BEE may be hindering Telkom's plans to offload redundant real estate, says Gugu Lourie.

Data provided by iNet BFA
Loading...
See More

Cipla mum on why it suspended CEO

Aug 16 2012 13:06 Reuters

Related Articles

Cipla shares plummet on CEO suspension

Cipla warns on earnings drop

Bitter pill to slowly swallow

More India ties may be Cipla Medpro remedy

Indian drug firms thrive in SA

Cipla Medpro suspends CEO

 

Cape Town - South African drug maker Cipla Medpro [JSE:CMP] said on Thursday the suspension of its chief executive was not based on any major financial wrong-doing, even as nervous investors sent its shares sharply lower.

South Africa's third-largest pharmaceutical firm said late on Wednesday it had suspended company founder Jerome Smith pending an investigation into "serious allegations", without identifying the charges.

Chairperson Sbu Luthuli declined to give details at the company's earnings presentation in Cape Town on Thursday.

"We can't disclose the nature and specifics, but I want to assure everyone that the matter is serious. But from a monetary value, if you look at the company, it is not material," he said.

"I want you to be at ease. You are not going to think that suddenly there is R100m missing from the company."

Investors nonetheless sent shares of the $450m drug maker sharply lower.

The shares were down 5.8% at R7.80 at 12:19, after earlier falling more than 10%.

Luthuli said the investigation would not impact Cipla Medpro's supply agreement with Indian drug giant Cipla Ltd.

Cipla Medpro has appointed Johan du Preez, an independent non-executive director, as acting chief executive, pending the outcome of the investigation.

Separately, the company reported a 31% increase in first-half earnings on Thursday.

* Follow Fin24 on Facebook, Twitter and Google+.



cipla medpro  |  drugs
NEXT ON FIN24X

AstraZeneca raises forecasts

2014-07-31 12:19

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
1 comment
Add your comment
Comment 0 characters remaining
 

Company Snapshot

We're talking about:

Small Business

A cash flow crunch often occurs in small businesses trying to balance cash coming in with cash going out. Watch this video to help you improve.
 
 

No need to keep up with the Joneses

Fin24 users provide their own personal tips on how to save money instead of trying to keep up with the Joneses.

 
 

Start saving...

Where can you stash your cash?
Time the key for retirement saving
Dummy's guide to saving
Save money with affordable account

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Loading...